Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

roche__tree

Roche posts positive mid-stage trial results for atezolizumab

July 13, 2015 Research and Development Genentech, PD-L1, Phase II, Roche, anti-PD-L1, atezolizumab, clinical trial, immuno-oncology, personalised medicine

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …
News

Novo Nordisk pushes forward with new diabetes drug trial

July 13, 2015 Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …
News
hugh-sampson-10

Allergy expert Dr Hugh Sampson joing DBV Technologies

July 9, 2015 Research and Development DBV Technologies, Viaskin

DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …
Appointment
Logos

Praluent scores positive trial results in Japan

July 9, 2015 Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …
News
Deopmed logo

Horizon attempts a hostile $3bn Depomed takeover

July 9, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover

Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …
News
Novartis image

Novartis wins US nod for new heart drug

July 8, 2015 Research and Development, Sales and Marketing Entestro, FDA, LCZ696, Novartis, ejection fraction, heart failure, reduced ejection fraction, sacubitril

The FDA has given the green light to Novartis’ new heart failure drug, six weeks ahead of the scheduled date …
News
23andme logo

23andMe targets $150 million for drug development

July 8, 2015 Research and Development 23andME, DNA, DNA testing, genetics, venture capital

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
News
bayer_alexander_moscho_thumbnail

European medicines group appoints Bayer’s Alex Moscho as new chair

July 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, EMG, European Medicines Group

Leading UK industry group the European Medicines Group (EMG) has elected Dr Alexander Moscho, the managing director of Bayer UK …
Appointment
Bayer's Alexander Moscho

Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho

July 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer

How did you find your way into your current role?I think it started when I was young and I was …
Feature

Adam Zaeske appointed as managing director of Takeda UK and Ireland

July 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda

Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …
Appointment
Vertex logo

Vertex’s cystic fibrosis drug gets FDA approval

July 3, 2015 Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy

Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …
News
Drug R&D

Pharma outsourcing: CROs, CMOs and external collaboration

July 2, 2015 Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing

Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …
Feature
dr_goddard

Mission Therapeutics appoints Dr Colin Goddard to its board of directors

July 2, 2015 Research and Development Colin Goddard, Mission Therapeutics, appointments

MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …
Appointment
Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015 Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …
News

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015 Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025